SCHEMBL2907657

SCHEMBL2907657

Cc1noc(C)c1S(=O)(=O)Nc1ccc(NC(=O)c2cc(N3C(=O)CCNC3=O)cc(C(C)(C)C)c2O)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.45
POLB P06746 2/20 0.45
TP53 P04637 1/20 0.45
ALDH1A1 P00352 4/20 0.45
GAA P10253 2/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
GALK1 P51570 1/20 0.44
LMNA P02545 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
TSHR P16473 2/20 0.42
HTT P42858 4/20 0.41
HPGD P15428 2/20 0.41
PKM P14618 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913166 0.84 XDH (0.38) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL1530329 0.83 MAPT (0.45) MAPTPOLBTP53ALDH1A1GAA
SCHEMBL2910190 0.83 GPR27 (0.42) MEN1KMT2A
SCHEMBL2907832 0.80 BCL2L1 (0.34) POLB
SCHEMBL2913154 0.80 BCL2L1 (0.35) POLBALDH1A1HPGD
SCHEMBL2912963 0.79 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL2915315 0.79 KIF18A (0.35) POLB
SCHEMBL2910683 0.78 ALDH1A1 (0.36) MAPTALDH1A1GAALMNATSHR
SCHEMBL2910962 0.78 RAB9A (0.39) MAPTPOLBTP53ALDH1A1HSD17B10
SCHEMBL2913374 0.77 BCL2L1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed